| # | Drug | Count |
|---|---|---|
| 0 | MANNITOL | 5 |
| 1 | ADALIMUMAB | 3 |
| 2 | DABIGATRAN ETEXILATE | 2 |
| 3 | DABIGATRAN ETEXILATE MESYLATE | 2 |
| 4 | ESOMEPRAZOLE MAGNESIUM | 2 |
| 5 | FUROSEMIDE | 2 |
| 6 | GABAPENTIN | 2 |
| 7 | IBUPFROFEN | 2 |
| 8 | IBUPROFEN | 2 |
| 9 | IBUPROFEN 200 MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MANNITOL | 5 | 0.0010 |
| 1 | ZICONOTIDE ACETATE | 1 | 0.0004 |
| 2 | BACLOFEN INJECTION | 1 | 0.0003 |
| 3 | PYRIDOSTIGMINE BROMIDE ORAL | 1 | 0.0003 |
| 4 | MILNACIPRAN HYDROCHLORIDE | 1 | 0.0002 |
| 5 | PYRIDOSTIGMINE BROMIDE | 1 | 0.0001 |
| 6 | NUSINERSEN | 1 | 0.0001 |
| 7 | DRONABINOL | 1 | 0.0001 |
| 8 | ELVITEGRAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0001 |
| 9 | CETIRIZINE HCL | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Osmotic Diuretic [EPC] | 5 | 0.0010 |
| 1 | Cannabinoid [EPC] | 1 | 0.0001 |
| 2 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |
| 3 | Cholinesterase Inhibitor [EPC] | 1 | 0.0001 |
| 4 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 5 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 2 | 0.0000 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |